Dimer Health builds a post-discharge care model that pairs AiME, a proprietary clinician-developed clinical AI system, with licensed clinicians called Transitionists who manage the full episode of care from hospital discharge through recovery. AiME engages patients in real time, analyzes symptoms against medical history and medications, and detects early risk signals, escalating to a Transitionist when intervention is needed. The company reports operating across eight states with partnerships spanning 28 healthcare facilities and a regional payor, and has shown up to a 67% reduction in unnecessary readmissions, a net promoter score above 90, and 30% quarter-over-quarter revenue growth for four consecutive quarters. Founded in 2023 and headquartered in Florham Park, New Jersey, Dimer Health aims to expand its Transitionist model, deepen system and payor partnerships, and improve AiME’s predictive and automation capabilities to modernize discharge processes.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026